Skip to main content
. Author manuscript; available in PMC: 2016 Jul 28.
Published in final edited form as: Breast Cancer Res Treat. 2012 Jun 16;134(2):751–757. doi: 10.1007/s10549-012-2112-7

Table 1.

Characteristics of datasets

Reference Total No.
Patients (Events)
No. Patients (Events)
Included in Analysis
Key characteristics Adjuvant therapy
Wang et al 286 (107) 192 (73) Node negative None
Van de Vijver et
al
295(101) 212 (68) Stage 1–II, < 53
years
Chemotherapy (90),
hormones (20), both (20),
or none (165)
Desmedt et al 198 (91) 124 (33) Node negative None
Loi et al 263 (87) 224 (70) Stage I–II, ER+ Tamoxifen